Latest return on equity
Arrowhead Pharmaceuticals Return on equity
Direct answer
Arrowhead Pharmaceuticals's return on equity is -55.21%.
The verified market snapshot reports -55.21%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked September 6, 2026.
Get free Arrowhead Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Return on equity
- -55.21%
Explore related company data
View Arrowhead Pharmaceuticals's market capitalizationView Arrowhead Pharmaceuticals's price-to-book ratioView Arrowhead Pharmaceuticals's 52-week price rangeView Arrowhead Pharmaceuticals's revenue growthView Arrowhead Pharmaceuticals's profit marginView Arrowhead Pharmaceuticals's debt-to-equity ratioView all Arrowhead Pharmaceuticals key metricsReturn to Arrowhead Pharmaceuticals profile